Ospomyv, a biosimilar to Prolia, is indicated for postmenopausal women and men at high risk of fracture, while Xbryk, a ...

The FDA has approved Bavarian Nordic’s Vimkunya, the first virus-like particle (VLP) chikungunya vaccine for patients over 12 years of age. According to the company, approval was based on strong ...

Pharm Exec’s 20th Annual Pipeline Report examines the emerging drug development trends and surging investments in five ...

The FDA has approved Merilog (insulin-aspart-szjj), a biosimilar to Novolog (insulin aspart), for improving glycemic control ...

How one Big Pharma ad campaign is incorporating diversity as a driving force in improving the ways drugs are marketed ...

Approval of Adcetris provides a new treatment option for patients with relapsed or refractory large b-cell lymphoma who are ...

As part of the funding, Latent Labs aims to leverage generative artificial intelligence to computationally create novel ...

In this part of his Pharmaceutical Executive video interview, Ian Baer, Founder & CEO of Sooth, identifies strategies ...

Funding was led by New Enterprise Associates, with participation from Foresite Capital and multiple other investors.

Pathways to success for this key component of Europe’s new HTA regulation, where thinking beyond the purely technical will be ...

Gene Mack, Gain Therapeutics CEO, provides a look into the future of the company and the use of physics-based artificial ...

Robert F. Kennedy Jr. will serve as Secretary of Health and Human Services. 1 The US Senate voted 52-48 in favor of Kennedy ...